Compare Iris Energy Limited (IREN) vs Medtronic PLC (MDT) Price & Performance

Iris Energy LimitedTrade

Medtronic PLCTrade

Price performance (Past 24H)

Key statistics

Iris Energy Limited vs Medtronic PLC — how do they compare? Iris Energy Limited trades at $41.35 (market cap $14.37B), while Medtronic PLC trades at $82.79 (market cap $106.61B). The key difference: Medtronic PLC is far larger — about 7.4× Iris Energy Limited's market cap, and Medtronic PLC pays a 3.46% dividend while Iris Energy Limited pays none. Which is the better fit depends on your goals.

	IREN	MDT
Market Cap	$14.37B	$106.61B
Sector	Energy	Health
52-Week High	$76.41	$105.35
52-Week Low	$15.40	$73.75
Enterprise Value	$16.12B	$125.36B
Dividend Yield	—	3.46%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

IREN

Alger Spectra Fund Class A shares beat Russell 3000 Growth Index in Q2 2026.Seeking Alpha · 18 hours agoBullish Biotech, AI, and leveraged ETFs soar on corporate events and strong business updatesStuart Mooney · 1 day agoBullish IREN secures $2.8bn in AI cloud contracts, raising 2026 ARR target above $4bnGlobeNewsWire · 1 day agoBullish View details →

MDT

Medtronic launches AI-powered Touch Surgery Aide for real-time support in robotic surgeries.PRNewsWire · 15 hours agoBullish Medtronic to report Q1 FY2027 financial results on September 1, 2026PRNewsWire · 1 day agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

About Iris Energy Limited

Iris Energy is a next-generation data center company that powers Bitcoin mining and AI workloads using 100% renewable energy. It focuses on building sustainable infrastructure for the global digital economy.

About Medtronic PLC

One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.